BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33902556)

  • 1. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
    Zhang WZ; Hoffman KL; Schiffer KT; Oromendia C; Rice MC; Barjaktarevic I; Peters SP; Putcha N; Bowler RP; Wells JM; Couper DJ; Labaki WW; Curtis JL; Han MK; Paine R; Woodruff PG; Criner GJ; Hansel NN; Diaz I; Ballman KV; Nakahira K; Choi ME; Martinez FJ; Choi AMK; Cloonan SM
    Respir Res; 2021 Apr; 22(1):126. PubMed ID: 33902556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
    Zhang WZ; Rice MC; Hoffman KL; Oromendia C; Barjaktarevic IZ; Wells JM; Hastie AT; Labaki WW; Cooper CB; Comellas AP; Criner GJ; Krishnan JA; Paine R; Hansel NN; Bowler RP; Barr RG; Peters SP; Woodruff PG; Curtis JL; Han MK; Ballman KV; Martinez FJ; Choi AM; Nakahira K; Cloonan SM; Choi ME;
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 31895696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
    Putcha N; Fawzy A; Paul GG; Lambert AA; Psoter KJ; Sidhaye VK; Woo J; Wells JM; Labaki WW; Doerschuk CM; Kanner RE; Han MK; Martinez C; Paulin LM; Martinez FJ; Wise RA; O'Neal WK; Barr RG; Hansel NN;
    Ann Am Thorac Soc; 2018 Jun; 15(6):710-717. PubMed ID: 30726108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).
    Zeidler MR; Martin JL; Kleerup EC; Schneider H; Mitchell MN; Hansel NN; Sundar K; Schotland H; Basner RC; Wells JM; Krishnan JA; Criner GJ; Cristenson S; Krachman S; Badr MS;
    Sleep; 2018 May; 41(5):. PubMed ID: 29534240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.
    Konokhova Y; Spendiff S; Jagoe RT; Aare S; Kapchinsky S; MacMillan NJ; Rozakis P; Picard M; Aubertin-Leheudre M; Pion CH; Bourbeau J; Hepple RT; Taivassalo T
    Skelet Muscle; 2016; 6():10. PubMed ID: 26893822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Fawzy A; Putcha N; Paulin LM; Aaron CP; Labaki WW; Han MK; Wise RA; Kanner RE; Bowler RP; Barr RG; Hansel NN;
    Respir Res; 2018 Jan; 19(1):20. PubMed ID: 29373977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combining manual therapy with exercise for mild chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
    Engel RM; Wearing J; Gonski P; Vemulpad S
    Trials; 2017 Jun; 18(1):282. PubMed ID: 28623944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
    Koo HK; Hoth KF; Make BJ; Regan EA; Crapo JD; Silverman EK; DeMeo DL
    Respir Res; 2022 Jan; 23(1):19. PubMed ID: 35093071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS.
    Oh AL; Mularski RA; Barjaktarevic I; Barr RG; Bowler RP; Comellas AP; Cooper CB; Criner GJ; Han MK; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Paine R; Parekh TM; Peters SP; Christenson SA; Woodruff PG;
    Ann Am Thorac Soc; 2021 Nov; 18(11):1822-1831. PubMed ID: 33631079
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial.
    Furian M; Flueck D; Latshang TD; Scheiwiller PM; Segitz SD; Mueller-Mottet S; Murer C; Steiner A; Ulrich S; Rothe T; Kohler M; Bloch KE
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3529-3538. PubMed ID: 30464436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease.
    Liu SF; Kuo HC; Tseng CW; Huang HT; Chen YC; Tseng CC; Lin MC
    PLoS One; 2015; 10(9):e0138716. PubMed ID: 26394041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.